Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2010 - 2026)

Vertex Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.47 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 4.1% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (down 4.1% YoY), while the FY2025 annual figure was 0.5, up 2.32% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.47, down from 0.48 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.57 in Q1 2022, with the low at 0.44 in Q1 2024.
• The 5-year median for Asset Utilization Ratio is 0.49 (2025), against an average of 0.49.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio decreased 14.85% in 2023, then increased 11.94% in 2025.
• Vertex Pharmaceuticals' Asset Utilization Ratio stood at 0.51 in 2022, then fell by 13.35% to 0.44 in 2023, then advanced by 10.87% to 0.49 in 2024, then declined by 3.46% to 0.48 in 2025, then slipped by 1.36% to 0.47 in 2026.
• Business Quant data shows VRTX's Asset Utilization Ratio at 0.47 in Q1 2026, 0.48 in Q4 2025, and 0.48 in Q3 2025.